537 related articles for article (PubMed ID: 31377342)
1. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
[TBL] [Abstract][Full Text] [Related]
2. IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy.
Dreskin SC; Germinaro M; Reinhold D; Chen X; Vickery BP; Kulis M; Burks AW; Negi SS; Braun W; Chambliss JM; Eglite S; McNulty CMG
Pediatr Allergy Immunol; 2019 Dec; 30(8):817-823. PubMed ID: 31437325
[TBL] [Abstract][Full Text] [Related]
3. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
Orgel K; Burk C; Smeekens J; Suber J; Hardy L; Guo R; Burks AW; Kulis M
Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
[TBL] [Abstract][Full Text] [Related]
4. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Vickery BP; Scurlock AM; Kulis M; Steele PH; Kamilaris J; Berglund JP; Burk C; Hiegel A; Carlisle S; Christie L; Perry TT; Pesek RD; Sheikh S; Virkud Y; Smith PB; Shamji MH; Durham SR; Jones SM; Burks AW
J Allergy Clin Immunol; 2014 Feb; 133(2):468-75. PubMed ID: 24361082
[TBL] [Abstract][Full Text] [Related]
5. Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.
Tsai M; Mukai K; Chinthrajah RS; Nadeau KC; Galli SJ
J Allergy Clin Immunol; 2020 Mar; 145(3):885-896.e6. PubMed ID: 31805311
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing IgG
Keswani T; LaHood NA; Marini-Rapoport O; Karmakar B; Andrieux L; Reese B; Sneed SL; Pedersen LC; Mueller GA; Patil SU
J Allergy Clin Immunol; 2024 Jun; 153(6):1611-1620.e7. PubMed ID: 38460677
[TBL] [Abstract][Full Text] [Related]
7. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy.
Nozawa A; Okamoto Y; Movérare R; Borres MP; Kurihara K
Pediatr Allergy Immunol; 2014 Jun; 25(4):323-8. PubMed ID: 24953293
[TBL] [Abstract][Full Text] [Related]
8. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.
Thyagarajan A; Jones SM; Calatroni A; Pons L; Kulis M; Woo CS; Kamalakannan M; Vickery BP; Scurlock AM; Wesley Burks A; Shreffler WG
Clin Exp Allergy; 2012 Aug; 42(8):1197-205. PubMed ID: 22805467
[TBL] [Abstract][Full Text] [Related]
9. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
Wisniewski JA; Commins SP; Agrawal R; Hulse KE; Yu MD; Cronin J; Heymann PW; Pomes A; Platts-Mills TA; Workman L; Woodfolk JA
Clin Exp Allergy; 2015 Jul; 45(7):1201-13. PubMed ID: 25823600
[TBL] [Abstract][Full Text] [Related]
11. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
[TBL] [Abstract][Full Text] [Related]
12. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
Vickery BP; Berglund JP; Burk CM; Fine JP; Kim EH; Kim JI; Keet CA; Kulis M; Orgel KG; Guo R; Steele PH; Virkud YV; Ye P; Wright BL; Wood RA; Burks AW
J Allergy Clin Immunol; 2017 Jan; 139(1):173-181.e8. PubMed ID: 27522159
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapy.
Kulis MD; Smeekens JM; Burk C; Yue X; Guo R; Orgel KA; Ye P; Herlihy L; Hamilton D; Li Q; Keet C; Shreffler W; Vickery BP; Burks AW; Kim EH
J Allergy Clin Immunol; 2022 Nov; 150(5):1144-1153. PubMed ID: 35716952
[TBL] [Abstract][Full Text] [Related]
14. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children.
van Erp FC; Knol EF; Pontoppidan B; Meijer Y; van der Ent CK; Knulst AC
J Allergy Clin Immunol; 2017 Jan; 139(1):358-360.e8. PubMed ID: 27516216
[No Abstract] [Full Text] [Related]
15. 2S protein Ara h 7.0201 has unique epitopes compared to other Ara h 7 isoforms and is comparable to 2S proteins Ara h 2 and 6 in basophil degranulation capacity.
Hayen SM; Ehlers AM; den Hartog Jager CF; Garssen J; Knol EF; Knulst AC; Suer W; Willemsen LEM; Otten HG
Clin Exp Allergy; 2018 Jul; 48(7):890-897. PubMed ID: 29542223
[TBL] [Abstract][Full Text] [Related]
16. Basophil response to peanut allergens in Mediterranean peanut-allergic patients.
Mayorga C; Gomez F; Aranda A; Koppelman SJ; Diaz-Perales A; Blanca-López N; Blazquez AB; Blanca M; Torres MJ
Allergy; 2014 Jul; 69(7):964-8. PubMed ID: 24816395
[TBL] [Abstract][Full Text] [Related]
17. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children.
Glaumann S; Nopp A; Johansson SG; Rudengren M; Borres MP; Nilsson C
Allergy; 2012 Feb; 67(2):242-7. PubMed ID: 22126416
[TBL] [Abstract][Full Text] [Related]
18. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
[TBL] [Abstract][Full Text] [Related]
19. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.
Kulis M; Chen X; Lew J; Wang Q; Patel OP; Zhuang Y; Murray KS; Duncan MW; Porterfield HS; W Burks A; Dreskin SC
Clin Exp Allergy; 2012 Feb; 42(2):326-36. PubMed ID: 22288514
[TBL] [Abstract][Full Text] [Related]
20. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
